[Federal Register Volume 85, Number 85 (Friday, May 1, 2020)]
[Notices]
[Pages 25452-25453]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09348]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2019-0069]


Proposed Update of the CDC's 2006 Revised Recommendations for HIV 
Testing of Adults, Adolescents, and Pregnant Women in Health-Care 
Settings; Re-opening of the Comment Period

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) in the 
Department of Health and Human Services (HHS) announces the re-opening 
of this docket to obtain additional public comment on the proposed 
update of the 2006 Revised Recommendations for HIV Testing. CDC is re-
opening this docket at the request of the public.

DATES: Electronic or written comments must be received by June 30, 
2020.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0069, by any of the following methods below. CDC does not accept public 
comment by email.
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: DHAP Guideline Team, Centers for Disease Control and 
Prevention, 1600 Clifton Road, NE, MS US8-4, Atlanta, Georgia 30329.

FOR FURTHER INFORMATION CONTACT: Priya Jakhmola, Health Scientist, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS 
US8-4, Atlanta, Georgia 30329. Telephone: 404-639-2495, Email: 
[email protected].

SUPPLEMENTARY INFORMATION:

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data related to HIV 
screening approaches. In addition, CDC invites comments specifically on 
opt-out routine HIV testing, including, but not limited to:

 Suggestions for revisions, edits, and new additions
 Contemporary issues and new evidence
 Implementation barriers, challenges, and lessons learned
 Examples of innovative models, partnerships, and 
collaborations

    Please note that comments received, including attachments and other 
supporting materials, are part of the public record and are subject to 
public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your 
comments or supporting materials that you consider confidential or 
inappropriate for public disclosure. If you include your name, contact 
information, or other information that identifies you in the body of 
your comments, that information will be on public display. CDC will 
review all submissions and may choose to redact, or withhold, 
submissions containing private or proprietary information, 
inappropriate language, or examples of a mass-mail campaign. CDC will 
carefully consider all comments submitted in preparation of the final 
document and may revise the final document as appropriate.

Background

    On August 30, 2019, CDC published a notice (84 FR 45495) announcing 
the availability of a Proposed Update of the CDC's 2006 Revised 
Recommendations for HIV Testing of Adults, Adolescents, and Pregnant 
Women in Health-Care Settings. The comment period ended October 28, 
2019. CDC received a request from the public to re-open the comment 
period.
    The CDC guideline ``Revised Recommendations for HIV Testing of 
Adults, Adolescents, and Pregnant Women in Health-Care Settings'' was 
published on September 22, 2006 in CDC's Morbidity and Mortality Weekly 
Report (MMWR). Since then, there have been changes in evidence related 
to HIV testing technologies and interventions, disease epidemiology, 
outcomes, implementation resources, and related guidelines. This 
evidence will be identified, assessed, and analyzed to inform the 
update of the guideline.
    CDC will update the 2006 guideline based on input from subject 
matter experts, public health agencies, the public, and other 
stakeholders. The guideline development process will draw on up-to-date 
nationally and internationally accepted guideline

[[Page 25453]]

development criteria, tools, and resources, including CDC guideline 
development standards. The process will include a rigorous systematic 
review of key questions formulated through the PICO (Patient-
Intervention-Comparator-Outcome) method. PICO is the foundation of an 
evidence-based process and facilitates the search for relevant evidence 
by identifying key concepts and formulating a search strategy. Graded 
recommendations will be developed using quality and strength of 
underlying evidence.
    Throughout the process of updating the guideline, there will be 
multiple opportunities for the public to comment on the drafts. We 
welcome input from a diverse range of perspectives, which will inform 
the development of the guideline, improve its credibility, and increase 
the transparency of the process.

    Dated: April 28, 2020.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2020-09348 Filed 4-30-20; 8:45 am]
BILLING CODE 4163-18-P